Utilising Third Party Fund Administrators

Coca-Cola Co., the world’s largest beverage company, will buy China’s Xiamen Culiangwang Beverage Technology Co. for about $400 million in cash, gaining a line of plant- based protein drinks in a renewed push into the Asian market.

2016 Global Excellence Awards - Best Capital Raise in Africa award winner is Verdant Capital, an investment bank operating on a pan-African basis. We invited them to write about their firm’s vital work in the midmarket financial services sector and their ref

Markets reward novelty, so portfolios often drift toward whatever has been rising. Digital holdings can expand quietly until one platform or theme dominates day-to-day wealth planning. Balancing digital growth with tangible asset security starts with clear def

Global green and sustainability sukuk issuance totalled $4.4 billion during the first half of 2022, following a record annual issuance of $6.1 billion in 2021, according to data published by the High-Level Working Group (HLWG) on Green and Sustainability Sukuk

The success of any business depends on a series of factors that converge toward one big goal - customer satisfaction. But, in order to learn what works and doesn’t, managers need to constantly optimize and reassess the current status

Almost every business across the globe is using mobile devices to optimise processes, streamline workflows and increase workforce productivity. But, as 5G becomes established and digital transformation earns commonplace, what is in store for enterprise mobilit

Advisory Group AG offers a wide range of strategic change advisory services from strategy design to successful implementation and transformation. Following the firm’s recognition in the 2022 AI Leading Advisor Awards as the ‘Leading Boutique Management Con

It’s a mantra that seems almost as old as time itself, but the ‘be fearful when others are greedy, and greedy when others are fearful’ strategy of Warren Buffett has served him well in more than five decades as an investor.

Venture capitalists invested US$2.8bn in life sciences in the fourth quarter, reaching US$8.6bn in 2014, according to MoneyTree Report from PwC.